Announcements

/Announcements

February 2017

Interpace Diagnostics to Present New Data on Thyroid Product Performance

PARSIPPANY, N.J., Feb. 27, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), [...]

Interpace Diagnostics Enters into Collaborative Agreement with Viatar CTC Solutions to Detect and Characterize Early Cancer in Liquid Biopsies

PARSIPPANY, N.J., Feb. 21, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" [...]

Interpace Diagnostics to Present at 2017 BIO CEO & Investor Conference

PARSIPPANY, N.J., Feb. 10, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) ("Interpace" [...]

Interpace Diagnostics Announces Closing of $3.9 Million Public Offering

PARSIPPANY, N.J., Feb. 8, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG)("Interpace" or [...]

Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million

PARSIPPANY, N.J., Feb. 3, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG)("Interpace" or [...]

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

PARSIPPANY, N.J., Feb. 2, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" [...]

January 2017

Interpace Diagnostics to Present at NobleCon13

PARSIPPANY, N.J., Jan. 25, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc., (NASDAQ: IDXG), [...]

Interpace Diagnostics Announces International Expansion of Thyroid Testing

PARSIPPANY, N.J., Jan. 24, 2017 /PRNewswire/ -- Interpace Diagnostics Corp. (NASDAQ: IDXG), a [...]

Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock

PARSIPPANY, N.J., Jan. 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG)("Interpace" or [...]

Interpace Diagnostics Announces New Partnership with Israeli Specialty Services Provider

PARSIPPANY, N.J., Jan. 20, 2017 /PRNewswire/ -- Interpace Diagnostics Corp. ("Interpace" or the [...]